Cart
sales@molnova.com
2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI
CAS No. 109909-44-6
2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI( —— )
Catalog No. M20808 CAS No. 109909-44-6
2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI Oxidation contributes to antibiotic lethality in stationary-phase mycobacteria.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 58 | In Stock |
|
| 50MG | 126 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI
-
NoteResearch use only, not for human use.
-
Brief Description2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI Oxidation contributes to antibiotic lethality in stationary-phase mycobacteria.
-
Description2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI Oxidation contributes to antibiotic lethality in stationary-phase mycobacteria.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number109909-44-6
-
Formula Weight533.1
-
Molecular FormulaC9H13N3Na3O13P3??
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 250 mg/mL (468.96 mM)
-
SMILESNc1ccn(C2CC(O)C(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)O2)c(=O)n1.[Na+].[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Br J Clin Pharmacol. 2000 Dec;50(6):597-604.et al.The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells.Kewn S Hoggard PG Sales SD
molnova catalog
related products
-
PHGDH-inactive
PHGDH inactive is inactive against PHGDH and serves as a negative control for NCT-502 and NCT-503 .
-
L-BMAA hydrochloride
L-BMAA hydrochloride is a neurotoxin produced by cyanobacteria.
-
Integerrimine
Prenatal exposure to Integerrimine N-oxide induces maternal toxicity, impairment of maternal care and delayed in physical and behavioral development of the offspring. Doses of Integerrimine N-oxide here employed did not produce marked immunotoxic effects.
